ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

In Brief: MB Withdraws From Fight Over Funding New Constructions, Tosses The Ball To Ted Cooper

January 9, 1976

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983

Society Growth continues, With OS The Largest; ASCO Plans to Reduce flow Of Medical Oncologists; AACR To Impose Page Charges for “Cancer Research:

May 31, 1985

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012